Xtant Medical Holdings, Inc. (XTNT) Social Stream

Xtant Medical Holdings, Inc. (XTNT): $0.70

0.05 (-6.53%)

POWR Rating

Component Grades









The tables below show the price targets and recommendations analysts covering XTNT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2023-04-26 1 $1 $1 $1 $1.28 -21.88%
2023-07-11 1 $1.2 $1.2 $1.2 $1.28 -6.25%
2023-12-05 2 $2 $1.2 $1.6 $1.28 25%
NA 1 $NA $NA $NA $1.28 NA%

Price Target Last Issued July 11, 2023

XTNT reports an average of 42.73% for its upside potential over the past 32 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-26 1 1.0 1.0 1.0 0.627 59.49%
2023-07-11 1 1.2 1.2 1.2 0.810 48.15%
2023-07-11 2 1.2 1.2 1.2 0.810 48.15%
2023-12-05 2 2.0 1.2 1.6 1.390 15.11%

XTNT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, XTANT MEDICAL HOLDINGS INC's number of analysts covering the stock is greater than 5.66% of them.
  • XTANT MEDICAL HOLDINGS INC's average analyst price target is higher than 0.96% of all US stocks.
  • In terms of how XTANT MEDICAL HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 66.22% of that group.
  • XTNT has a higher upside potential (average analyst target price relative to current price) than 52.04% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to XTANT MEDICAL HOLDINGS INC are ADMA, VXRT, and PSTX.

Make investment decisions regarding XTNT using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!